🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,867 results for “De” Clear

  1. Skin stretching device (SSD)

    The First People's Hospital of Lianyungang

    Trauma

    approved other active

    1 trial

  2. Sodium Bicarbonate Ringer's Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    approved small molecule active

    1 trial

  3. Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Disc Medicine

    Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

    approved small molecule active

    1 trial

  4. Sodium Chloride Fresenius Kabi Italia 0,9 % Solution for infusion, MabThera 500 mg concentrate for solution for infusion

    Disc Medicine

    Systemic sclerosis

    approved small molecule active

    1 trial

  5. Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion , DENOSUMAB, Sodium Fluoride (18F) Life Radiopharma 0,1 - 4 GBq/ml solution injectable

    Disc Medicine

    Fibrous dysplasia/McCune-Albright syndrome

    approved small molecule active

    1 trial

  6. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    REM Sleep Behavior Disorder

    approved small molecule completed

    1 trial

  7. Solriamfetol

    Jazz Pharmaceuticals Ireland Limited

    Binge Eating Disorder

    approved small molecule active

    1 trial

  8. Songling Xuemaikang Capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension,Essential

    approved small molecule active

    1 trial

  9. Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

    Moderna Biotech Spain

    SARS-CoV-2 infection

    approved small molecule active

    1 trial

  10. Standard clinical care first, followed by standard clinical care and varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved small molecule completed

    1 trial

  11. Stimulant or sedative

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  12. Subcutaneous HYLENEX (recombinant human hyaluronidase) and Lactated Ringer's solution

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule terminated

    1 trial

  13. Subcutaneous depot medroxyprogesterone acetate

    Protara Therapeutics

    Contraception

    approved small molecule completed

    1 trial

  14. Subcutaneous glargine insulin

    Lxo Ireland Designated Activity Company

    Diabetes Mellitus

    approved small molecule completed

    1 trial

  15. Sublingual film containing Igalmi

    BioXcel Therapeutics

    Bipolar Disorder

    approved small molecule completed

    1 trial

  16. Sublocade

    Indivior Pty Ltd

    Opioid Use Disorder, Severe

    approved small molecule completed

    1 trial

  17. Suboxone Sublingual Film

    Indivior Pty Ltd

    Opioid Dependence

    approved small molecule completed

    1 trial

  18. Suboxone, Buprenorphine Hydrochloride + Naloxone, SCH 484

    Indivior Pty Ltd

    Opiate Dependence

    approved small molecule completed

    1 trial

  19. Subutex 300 mg injektionsvätska, depotlösning, Subutex 100 mg injektionsvätska, depotlösning

    Indivior Pty Ltd

    Opioid Use Disorder

    approved small molecule active

    1 trial

  20. Succinylcholine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    the Effect of Succinylcholine on Barrier Pressure

    approved small molecule completed

    1 trial

  21. Sugammadex hameln 100 mg/ml oplossing voor injectie, Naloxon HCl Accord 0,4 mg/ml, oplossing voor injectie / infusie in een voorgevulde spuit, ANEXATE 0,5 mg/5 ml, solution injectable (I.V.), REMIMAZOLAM , Sufentanil Viatris 5 microgram/ml oplossing voor injectie, Esmeron 10 mg/ml, oplossing voor injectie

    Disc Medicine

    General anesthesia

    approved small molecule active

    1 trial

  22. Sulfato de Magnesio Altan 150 mg/ml solución inyectable y para perfusión EFG, LIDOCAINE HYDROCHLORIDE, Dexdor 100 micrograms/ml concentrate for solution for infusion, KETOLAR 50 mg/ml solución inyectable.

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  23. Surabgene Lomparvovec (ABBV-RGX-314), Lucentis 10 mg/ml solution for injection in pre-filled syringe, Surabgene Lomparvovec (ABBV-RGX-314)

    AbbVie Deutschland GmbH & Co. KG

    Neovascular age-related macular degeneration

    approved small molecule active

    1 trial

  24. Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

    GT Biopharma

    Glioblastoma

    approved other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources